Approvals/TGA/ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule

Approved

STANDARD

ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule

Fresenius Kabi Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bb4ea13e66f8d9dd
Product Name: ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule
Artg Id: 195804
Artg Name: ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule
Sponsor: Fresenius Kabi Australia Pty Ltd
Company Detail Path: /organization/fresenius-kabi-australia-pty-ltd
Artg Date: 2013-06-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-CMI-01902-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2013-PI-01903-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

bb4ea13e66f8d9dd

Type

Standard